134 related articles for article (PubMed ID: 8324080)
1. The role of iron in the cytotoxicity of tumor necrosis factor.
Warren S; Torti SV; Torti FM
Lymphokine Cytokine Res; 1993 Apr; 12(2):75-80. PubMed ID: 8324080
[TBL] [Abstract][Full Text] [Related]
2. The adenylate cyclase activator forskolin partially protects L929 cells against tumour necrosis factor-alpha-mediated cytotoxicity via a cAMP-independent mechanism.
Uboldi AD; Savage N
Cytokine; 2002 Sep; 19(5):250-8. PubMed ID: 12393172
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine.
Beyaert R; Vanhaesebroeck B; Heyninck K; Boone E; De Valck D; Schulze-Osthoff K; Haegeman G; Van Roy F; Fiers W
Cancer Res; 1993 Jun; 53(11):2623-30. PubMed ID: 8495426
[TBL] [Abstract][Full Text] [Related]
4. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
[TBL] [Abstract][Full Text] [Related]
5. Change of membrane potential is not required for the tumour necrosis factor-alpha mediated cytotoxicity.
Kong SK; Chan PC; Choy YM; Fung KP; Lee CY
Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):57-68. PubMed ID: 7680677
[TBL] [Abstract][Full Text] [Related]
6. Augmentation by IL-1 alpha of tumor necrosis factor-alpha cytotoxicity in cells transfected with adenovirus E1A.
Tsuji Y; Ninomiya-Tsuji J; Torti SV; Torti FM
J Immunol; 1993 Mar; 150(5):1897-907. PubMed ID: 8436824
[TBL] [Abstract][Full Text] [Related]
7. Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts.
Pizzo P; Murgia M; Zambon A; Zanovello P; Bronte V; Pietrobon D; Di Virgilio F
J Immunol; 1992 Nov; 149(10):3372-8. PubMed ID: 1431111
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells.
Vercammen D; Vandenabeele P; Beyaert R; Declercq W; Fiers W
Cytokine; 1997 Nov; 9(11):801-8. PubMed ID: 9367540
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of mutants of human tumour necrosis factor-alpha.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
[TBL] [Abstract][Full Text] [Related]
10. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity.
Hennet T; Bertoni G; Richter C; Peterhans E
Cancer Res; 1993 Mar; 53(6):1456-60. PubMed ID: 8443823
[TBL] [Abstract][Full Text] [Related]
11. B cells induce apoptosis via a novel mechanism in fibroblasts infected with mouse hepatitis virus.
Nishioka WK; Welsh RM
Nat Immun; 1993; 12(3):113-27. PubMed ID: 8392406
[TBL] [Abstract][Full Text] [Related]
12. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death.
Wu Y; Tewari M; Cui S; Rubin R
J Cell Physiol; 1996 Sep; 168(3):499-509. PubMed ID: 8816904
[TBL] [Abstract][Full Text] [Related]
13. Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-alpha binding to mediate cytotoxicity and nitric oxide generation.
Jiang H; Stewart CA; Tan SY; Fast DJ; Rummage JA; Leu RW
Cell Immunol; 1996 Feb; 167(2):293-301. PubMed ID: 8603439
[TBL] [Abstract][Full Text] [Related]
14. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro.
Zinetti M; Galli G; Demitri MT; Fantuzzi G; Minto M; Ghezzi P; Alzani R; Cozzi E; Fratelli M
Immunology; 1995 Nov; 86(3):416-21. PubMed ID: 8550079
[TBL] [Abstract][Full Text] [Related]
15. Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929 cells.
Kim YH; Kim SS
Cytokine; 1999 Apr; 11(4):274-81. PubMed ID: 10328866
[TBL] [Abstract][Full Text] [Related]
16. Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells.
Autelli R; Crepaldi S; De Stefanis D; Parola M; Bonelli G; Baccino FM
Apoptosis; 2005 Aug; 10(4):777-86. PubMed ID: 16133868
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
Habtemariam S
J Nat Prod; 1997 Aug; 60(8):775-8. PubMed ID: 9287415
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells.
Smith MR; Munger WE; Kung HF; Takacs L; Durum SK
J Immunol; 1990 Jan; 144(1):162-9. PubMed ID: 2153163
[TBL] [Abstract][Full Text] [Related]
19. Modes of L929 cell death induced by TNF-alpha and other cytotoxic agents.
Humphreys DT; Wilson MR
Cytokine; 1999 Oct; 11(10):773-82. PubMed ID: 10525316
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of tumor necrosis factor cytotoxicity by lithium chloride is associated with increased inositol phosphate accumulation.
Beyaert R; Heyninck K; De Valck D; Boeykens F; van Roy F; Fiers W
J Immunol; 1993 Jul; 151(1):291-300. PubMed ID: 8392097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
